Expert Interview
A second look: Discussing the potential of Axsome's drug AXS-14 (esreboxetine) for the treatment of Fibromyalgia.
Ticker(s): AXSMInstitution: Murphy Pain Center & University of Louisville School of Medicine.
- Medical Director of Murphy Pain Center, Assistant Clinical Professor at ULSOM, Dr. Murphy is an anesthesiologist and interventional pain specialist who was one of the nation’s first physicians board-certified in both Pain Medicine and Addiction Medicines, after completing his fellowship at the Mayo Clinic.
- Extensive experience will all aspects of opioid use with 100% of practice dedicated to the treatment of chronic severe pain. ~10 patients on NUCYNTA ER (tapentadol)
- Worked with regulators in crafting prescription guidelines, contributes to numerous publications and has presented before national and international audiences regarding pain and addiction.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
